Dr. Engel joined Cytochroma as Vice President of Regulatory Affairs and Quality Assurance in September 2008.  He brings an established track record of drug and biologic development expertise having held increasingly more senior positions of responsibility for global regulatory strategy, registrations and quality compliance functions in companies such as Cyanamid, Abbott Laboratories, Otsuka, Baxter Healthcare, Cubist, Vertex and Par Pharmaceuticals, acting as Vice President in the last four.  He has led successful registrations for 10 new products across therapeutic areas including chronic kidney disease and oncology.  Prior to the pharmaceutical industry, he spent several years in academia conducting clinical trials, pharmacokinetic and applied laboratory pharmacology studies.  Dr. Engel received bachelor's degrees in pharmacy and biology from Drake University, M.Sc. in pharmacology from the University of North Carolina at Chapel Hill and a Pharm.D. from the University of Florida.